Epithelial injury induces an innate repair mechanism linked to cellular senescence and fibrosis involving IGF-binding protein-5

Journal of Endocrinology

Volumn 199, Issue 2, 2008, Pages 155-164

  Allan, Gordon J ^a   Beattie, James ^a   Flint, David J ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRONECTIN; PROTEINASE ACTIVATED RECEPTOR 1; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CELL AGING; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; EMBRYO DEVELOPMENT; EPITHELIUM CELL; FIBROBLAST; FIBROGENESIS; FIBROSING ALVEOLITIS; FIBROSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FIBROSIS; LIVER CIRRHOSIS; LUNG FIBROSIS; MACROPHAGE ACTIVATION; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; SYSTEMIC SCLEROSIS;

ANIMALS; CELL AGING; EPITHELIUM; FIBROSIS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; MESENCHYMAL STEM CELLS; MODELS, BIOLOGICAL;

EID: 56849118244     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0269     Document Type: Review

References (98)

1. Abreu JG, Ketpura NI, Reversade B & De Robertis EM 2002 Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β. Nature Cell Biology 4 599-604.
2. Allan GJ, Hint DJ, Darling SM, Geh J & Patel K 2000 Altered expression of insulin-like growth factor-1 and insulin like growth factor binding proteins-2 and 5 in the mouse mutant Hypodactyly (Hd) correlates with sites of apoptotic activity. Anatomica Embryologica 202 1-11.
3. Allan GJ, Flint DJ & Patel K 2001 Insulin-like growth factor axis during embryonic development. Reproduction 122 31-39.
4. Allander SV, Coleman M, Luthman H & Powell DR 1997 Chicken insulin-like growth factor binding protein (IGFBP)-5: conservation of IGFBP-5 structure and expression during evolution. Comparative Biochemistry and Physiology. Part B, Biochemistry and Molecular Biology 116 477-483.
5. Amaar YG, Thompson GR, Linkhart TA, Chen ST, Baylink DJ & Mohan S 2002 Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2). Journal of Biological Chemistry 277 12053-12060.
6. Amaar YG, Baylink DJ & Mohan S 2005 Ras-association domain family 1 protein, RASSF1C, is an IGFBP-5 binding partner and a potential regulator of osteoblast cell proliferation. Journal of Bone and Mineral Research 20 1430-1439.
7. Andress DL 1998 Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation ofthe IGFBP-5 receptor. American Journal of Physiology 274 E744-E750.
8. Arai T, Arai A, Busby WH Jr & Clemmons DR 1994 Glycosaminoglycans inhibit degradation of insulin-like growth factor- binding protein-5. Endocrinology 135 2358-2363.
9. Beattie J, Allan GJ, Lochrie JD & Flint DJ 2006 Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis. Biochemical Journal 395 1-19.
10. Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P & Campisi J 2003 Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO Journal 22 4212-4222.
11. Best PJ, Hasdai D, Sangiorgi G, Schwartz RS, Holmes DR Jr, Simari RD & Lerman A 1999 Apoptosis. Basic concepts and implications in coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 19 14-22.
12. Bogatkevich GS, Gustilo E, Oates JC, Feghali-Bostwick C, Harley RA, Silver RM & Ludwicka-Bradley A 2005 Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts. American Journal of Physiology. Lung Cellular and Molecular Physiology 288 L190-L201.
13. Campbell PG & Andress DL 1997 Insulin-like growth factor (IGF)-binding protein-5-(201-218) region regulates hydroxyapatite and IGF-1 binding. American Journal of Physiology 273 E1005-E1013.
14. Campisi J 2005 Senescent cells, rumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120 513-522.
15. Capers QT, Alexander RW, Lou P, De Leon H, Wilcox JN, Ishizaka N, Howard AB & Taylor WR J997 Monocyte chemoattractant protem-1 expression in aortic tissues of hypertensive rats. Hypertension 30 1397-1402.
16. Carnell PH, Vito RP & Taylor WR 2007 Characterizing intramural stress and inflammation in hypertensive arterial bifurcations. Biomechanics and Modeling in Mechanobiology 6 409-421.
17. Chakravarthy MV, Abraha TW, Schwartz RJ, Fiorotto ML & Booth FW 2000 Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3′-kinase/ Akt signaling pathway. Journal of Biological Chemistry 275 35942-35952.
18. Chambers RC 2008 Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention? British Journal of Pharmacology 153 (Suppl 1) S367-S378.
19. Chambers RC, Leoni P, Blanc-Brude OP, Wembridge DE & Laurent GJ 2000 Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. Journal of Biological Chemistry 275 35584-35591.
20. Clemmons DR, Busby WH, Arai T, Nam TJ, Clarke JB, Jones JI & Ankrapp DK 1995 Role of insulin-like growth factor binding proteins in the control of IGF actions. Progress in Growth Factor Research 6 357-366.
21. Costner MI &Jacobe H 2000 Dermatopathology of connective tissue diseases. Advances in Dermatology 16 323-359 (discussion 360).
22. Deng X, Mercer PF, Scotton CJ, Gilchrist A & Chambers RC 2008 Thrombin induces fibroblast CCL2/JE production and release via coupling of PAR1 to Gαq and cooperation between ERK1/2 and Rho kinase signaling pathways. Molecular Biology of the Cell 19 2520-2533.
23. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O et al. 1995 A biomarker that identifies senescent human cells in culture and in aging skin in vivo. PNAS 92 9363-9367.
24. Effros RB 2007 Telomerase induction in T cells: a cure for aging and disease? Experimental Gerontology 42 416-420.
25. Eyden B 2001 The myofibroblast: an assessment of controversial issues and a definition useful in diagnosis and research. Ultrastructural Pathology 25 39-50.
26. Feghali CA & Wright TM 1999 Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis. Arthritis and Rheumatism 42 1451-1457.
27. Firth SM & Baxter RC 1995 The role of glycosylation in the action of IGFBP-3. Progress in Growth Factor Research 6 223-229.
28. Flint DJ, Tonner E & Allan GJ 2000 Insulin-like growth factor binding proteins: IGF-dependent and -independent effects in tile mammary gland. Journal of Mammary Gland Biology and Neoplasia 5 65-73.
29. Garcia CK, Wright WE & Shay JW 2007 Human diseases of telomerase dysfunction: insights into tissue aging. Nucleic Acids Research 35 7406-7416.
30. Gross TJ & Hunninghake GW 2001 Idiopathic pulmonary fibrosis. New England Journal of Medicine 345 517-525.
31. Guenette RS & Tenniswood M 1994 The role of growth factors in the suppression of active cell death in the prostate: an hypothesis. Biochemistry and Cell Biology 72 553-559.
32. Guest TM, Vlastos G, Alameddine FM & Taylor WR 2006 Mechanoregulation of monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells. Antioxidants and Redox Signaling 8 1461-1471.
33. Hampel B, Fortschegger K, Ressler S, Chang MW, Unterluggauer H, Breitwieser A, Sommergruber W, Fitzky B, Lepperdinger G, Jansen-Durr P et al. 2006 Increased expression of extracellular proteins as a hallmark of human endothelial cell in vitro senescence. Experimental Gerontology 41 474-481.
34. Hayflick L & Moorhead PS 1961 The serial cultivation of human diploid cell strains. Experimental Cell Research 25 585-621.
35. Highland KB & Silver RM 2005 New developments in scleroderma interstitial lung disease. Current Opinions in Rheumatology 17 737-745.
36. Holzenberger M 2004 The GH/IGF-1 axis and longevity. European Journal of Endocrinology 151 (Suppl 1) S23-S27.
37. Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, Cervera P & Le Bouc Y 2003 IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421 182-187.
38. Howell DC, Goldsack NR, Marshall RP, McAnulty RJ, Starke R, Purdy G, Laurent GJ & Chambers RC 2001 Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. American Journal of Pathology 159 1383-1395.
39. Howell DC, Johns RH, Lasky JA, Shan B, Scotton CJ, Laurent GJ & Chambers RC 2005 Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. American Journal of Pathology 166 1353-1365.
40. Inoki I, Shiomi T, Hashimoto G, Enomoto H, Nakamura H, Makino K, Ikeda E, Takata S, Kobayashi K & Okada Y 2002 Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB Journal 16 219-221.
41. Jabs A, Okamoto E, Vinten-Johansen J, Bauriedel G & Wilcox JN 2007 Sequential patterns of chemokine- and chemokine receptor-synthesis following vessel wall injury in porcine coronary arteries. Atherosclerosis 192 75-84.
42. Jacobs JJ & de Lange T 2004 Significant role for p16INK4a in p53-independent telomere-directed senescence. Current Biology 14 2302-2308.
43. Jenkins RG, Su X, Su G, Scotton CJ, Camerer E, Laurent GJ, Davis GE, Chambers RC, Matthay MA & Sheppard D 2006 Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-β activation and promotes acute lung injury. Journal of Clinical Investigation 116 1606-1614.
44. Jones JI, Gockerman A, Busby WH Jr, Camacho-Hubner C & Clemmons DR 1993 Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-1. Journal of Cell Biology 121 679-687.
45. Jurgeit A, Berlato C, Obrist P, Ploner C, Massoner P, Schmolzer J, Haffner MC, Mocker H, Huber LA, Geley S et al. 2007 Insulin-like growth factor-binding protein-5 enters vesicular structures but not the nucleus. Traffic 8 1815-1828.
46. Kenyon C 2001 A conserved regulatory system for aging. Cell 105 165-168.
47. Kim WH, Matsumoto K, Bessho K & Nakamura T 2005 Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. American Journal of Pathology 166 1017-1028.
48. Kim KS, Sea YB, Baek SH, Kim MJ, Kim KJ, Kim JH, & Kim JR 2007 Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. Molecular Biology of the Cell 18 4543-4552.
49. Kirk TZ, Mark ME, Chua CC, Chua BH & Mayes MD 1995 Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. Journal of Biological Chemistry 270 3423-3428.
50. Kissin E & Korn JH 2002 Apoptosis and myofibroblasts in the pathogenesis of systemic sclerosis. Current Rheumatology Reports 4 129-135.
51. Krumlauf R 1994 Hox genes invertebrate development. Cell 78 191-201.
52. Leask A & Abraham DJ 2004 TGF-beta signaling and the fibrotic response. FASEB Journal 18 816-827.
53. Le Roy EC 1992 A brief overview of the pathogenesis of scleroderma (systemic sclerosis). Annals of Rheumatic Disease 51 286-288.
54. Lin Y, Xie WF, Chen YX, Zhang X, Zeng X, Qiang H, Chen WZ, Yang XJ, Han ZG & Zhang ZB 2005 Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyre growth factor genes. Liver International 25 796-807.
55. Liu B, Weinzimer SA, Gibson TB, Mascarenhas D & Cohen P 2003 Type I alpha collagen is an IGFBP-3 binding protein. Growth Hormone and IGF Research 13 89-97.
56. Longo VD & Finch CE 2003 Evolutionary medicine: from dwarf model systems to healthy centenarians? Science 299 1342-1346.
57. Maiellaro K & Taylor WR 2007 The role of the adventitia in vascular inflammation. Cardiovascular Research 75 640-648.
58. Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ & Schottenfeld D 2003 Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis and Rheumatism 48 2246-2255.
59. Mohan S & Baylink DJ 2002 IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. Journal of Endocrinology 175 19-31.
60. Mohan S, Thompson GR, Amaar YG, Hathaway G, Tschesche H & Baylink DJ 2002 ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Biochemistry 41 15394-15403.
61. Morales TI 1997 The role and content of endogenous insulin-like growth factor-binding proteins in bovine articular cartilage. Archives of Biochemistry and Biophysics 343 164-172.
62. Mukherjee A & Rotwein P 2007 Insulin-like growth factor binding protein-5 in osteogenesis: facilitator or inhibitor? Growth Hormone and IGF Research 17 179-185.
63. Mukherjee A, Wilson EM & Rotwein P 2008 Insulin-like growth factor (IGF) binding protein-5 blocks skeletal muscle differentiation by inhibiting IGF actions. Molecular Endocrinology 22 206-215.
64. Nam TJ, Busby WH Jr & Clemmons DR 1994 Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5. Endocrinology 135 1385-1391.
65. Nam TJ, Busby WH Jr, Rees C & Clemmons DR 2000 Thrombospondin and oesteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-1-stimulated cell growth. Endocrinology 141 1100-1106.
66. Nguyen TQ & Goldschmeding R 2008 Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis? Pharmacological Research 25 2416-2426.
67. Ning Y, Hoang B, Schuller AG, Cominski TP, Hsu MS, Wood TL & Pintar JE 2007 Delayed mammary gland involution in mice with mutation of the insulin-like growth factor binding protein 5 gene. Endocrinology 148 2138-2147.
68. O'Donnell SL, Frederick TJ, Krady JK, Vannucci SJ & Wood TL 2002 IGF-1 and microglia/macrophage proliferation in the ischemic mouse brain. Glia 39 85-97.
69. Ohba T, McDonald JK, Silver RM, Strange C, LeRoy EC & Ludwicka A 1994 Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor. American Journal of Respiratory Cell and Molecular Biology 10 405-412.
70. Okamoto E, Couse T, De Leon H, Vinten-Johansen J, Goodman RB, Scott NA & Wilcox JN 2001 Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation 104 2228-2235.
71. Pagano PJ & Gutterman DD 2007 The adventitia: the outs and ins of vascular disease. Cardiovascular Research 75 636-639.
72. Park JI, Jeong JS, Han JY, Kim DI, Gao YH, Park SC, Rodgers GP & Kim IH 2000 Hydroxyurea induces a senescence-like change of K562 human erythroleukemia cell. Journal of Cancer Research and Clinical Oncology 126 455-460.
73. Park JY, Park YH, Shin DH & Oh SH 2007 Insulin-like growth factor binding protein (IGFBP)-mediated hair cell survival on the mouse utricle exposed to neomycin: the roles of IGFBP-4 and IGFBP-5. Acta Oto-Laryngologica 558 22-29.
74. Pilewski JM, Liu L, Henry AC, Knauer AV & Feghali-Bostwick CA 2005 Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. American Journal of Pathology 166 399-407.
75. Raghu G, Weycker D, Edelsberg J, Bradford WZ & Oster G 2006 Incidence and prevalence of idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 174 810-816.
76. Salih DA, Tripathi G, Holding C, Szestak TA, Gonzalez MI, Carter EJ, Cobb LJ, Eisemann JE & Pell JM 2004 Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. PNAS 101 4314-4319.
77. Sanz S, Pucilowska JB, Liu S, Rodriguez-Ortigosa CM, Lund PK, Brenner DA, Fuller CR, Simmons JG, Pardo A, Martinez-Chantar ML et al. 2005 Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury. Gut 54 134-141.
78. Sappino AP, Masouye I, Saurat JH & Gabbiani G 1990 Smooth muscle differentiation in scleroderma fibroblastic cells. American Journal of Pathology 137 585-591.
79. Schedlich LJ, Young TF, Firth SM & Baxter RC 1998 Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. Journal of Biological Chemistry 273 18347-18352.
80. Schneider MR, Wolf E, Hoeflich A & Lahm H 2002 IGF-binding protein-5: flexible player in the IGF system and effector on its own. Journal of Endocrinology 172 423-440.
81. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L & Wilcox JN 1996 Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93 2178-2187.
82. Scotton CJ & Chambers RC 2007 Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 132 1311-1321.
83. Selman M & Pardo A 2006 Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proceedings of the American Thoracic Society 3 364-372.
84. Serrano M, Lin AW, McCurrach ME, Beach D & Lowe SW 1997 Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88 593-602.
85. Shimokawa I, Higami Y, Utsuyama M, Tuchiya T, Komatsu T, Chiba T & Yamaza H 2002 Life span extension by reduction in growth hormone-insulin-like growth factor-1 axis in a transgenic rat model. American Journal of Pathology 160 2259-2265.
86. Shimokawa I, Higami Y, Tsuchiya T, Otani H, Komatsu T, Chiba T & Yamaza H 2003 Life span extension by reduction of the growth hormone-insulin-like growth factor-1 axis: relation to caloric restriction. FASFB Journal 17 1108-1109.
87. Smith JR & Pereira-Smith OM 1996 Replicative senescence: implications for in vivo aging and tumor suppression. Science 273 63-67.
88. Sorrell AM, Shand JH, Tonner E, Gamberoni M, Accorsi PA, Beattie J, Allan GJ & Flint DJ 2006 Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin. Journal of Biological Chemistry 281 10883-10889.
89. Steen V 2007 Scleroderma renal crisis. Indian Journal of Medical Sciences 61 71-72.
90. Takehara K 2003 Hypothesis: pathogenesis of systemic sclerosis. Journal of Rheumatology 30 755-759.
91. Tonner E, Barber MC, Allan GJ, Beattie J, Webster J, Whitelaw CB & Flint DJ 2002 Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice. Development 129 4547-4557.
92. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, Lu X, Soron G, Cooper B, Brayton C et al. 2002 p53 mutant mice that display early ageing-associated phenotypes. Nature 415 45-53.
93. Wagner M, Hampel B, Bernhard D, Hala M, Zwerschke W & Jansen-Durr P 2001 Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Experimental Gerontology 36 1327-1347.
94. Willis BC, Liebler JM, Luby-Phelps K, Nicholson AG, Crandall ED, du Bois RM & Borok Z 2005 Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. American Journal of Pathology 166 1321-1332.
95. Yasuoka H, Jukic DM, Zhou Z, Choi AM & Feghali-Bostwick CA 2006a Insulin-like growth factor binding protein 5 induces skin fibrosis: a novel murine model for dermal fibrosis. Arthritis and Rheumatism 54 3001-3010.
96. Yasuoka H, Zhou Z, Pilewski JM, Oury TD, Choi AM & Feghali-Bostwick CA 2006b Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration. American Journal of Pathology 169 1633-1642.
97. Yoon IK, Kim HK, Kim YK, Song IH, Kim W, Kim S, Baek SH, Kim JH & Kim JR 2004 Exploration of replicative senescence-associated genes in human dermal fibroblasts by cDNA microarray technology. Experimental Gerontology 39 1369-1378.
98. Zhu J, Woods D, McMahon M & Bishop JM 1998 Senescence of human fibroblasts induced by oncogenic Raf. Genes and Development 12 2997-3007.